APA (7th ed.) Citation

Dayanc, B., Eris, S., Gulfirat, N. E., Ozden-Yilmaz, G., Cakiroglu, E., Deniz, O. S. C., . . . Senturk, S. Integrative multi-omics identifies AP-1 transcription factor as a targetable mediator of acquired osimertinib resistance in non-small cell lung cancer. Nature Publishing Group.

Chicago Style (17th ed.) Citation

Dayanc, Bengisu, Sude Eris, Nazife Ege Gulfirat, Gulden Ozden-Yilmaz, Ece Cakiroglu, Ozlem Silan Coskun Deniz, Gökhan Karakülah, Serap Erkek-Ozhan, and Serif Senturk. Integrative Multi-omics Identifies AP-1 Transcription Factor as a Targetable Mediator of Acquired Osimertinib Resistance in Non-small Cell Lung Cancer. Nature Publishing Group.

MLA (9th ed.) Citation

Dayanc, Bengisu, et al. Integrative Multi-omics Identifies AP-1 Transcription Factor as a Targetable Mediator of Acquired Osimertinib Resistance in Non-small Cell Lung Cancer. Nature Publishing Group.